Project Grant R21DC022058
- This five-year, $734,582 Project Grant from the National Institute on Deafness and Other Communication Disorders will fund research at Lehigh University to investigate the developmental determination of central auditory physiology by the inner ear. The grant is part of the Research Related to Deafness and Communication Disorders program. Specifically, the university will develop a model of repatterned frequency representation in the chick inner ear by overexpressing the bone morphogenetic...
- This Project Grant, awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), supports fundamental neuroscience research investigating neural mechanisms of hearing loss recovery. Emory University received $345,650 in obligated funding (award date: June 15, 2025; completion date: December 15, 2027) to conduct chronic electrophysiological recording studies in mouse auditory...
- This Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal Research Related to Deafness and Communication Disorders program (CFDA 93.173), will support research to investigate the mechanisms underlying the olivocochlear system's ability to enhance cochlear function in mice. The $416,642 award, valid from July 2024 to June 2026, will enable researchers at the University of Rochester to: 1) isolate and systematically evaluate the...
- Federal Project Grant Award Summary Merrimack College received a $249,000 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), effective September 2, 2025, through August 31, 2028. The grant funds the development of a CRISPR-based toolkit for investigating transcription factors in hair cell development within inner ear organoids. The research will establish...
- This $610,725 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) supports research into the physiological mechanisms underlying suprathreshold deficits in sensorineural hearing loss. The project, titled "Physiological Determinants of Suprathreshold Deficits in Sensorineural Hearing Loss," will be conducted by researchers at the University of Pittsburgh from May 2, 2025 to April 30, 2030. The key objectives are to: 1) Characterize the...
- Federal Project Grant Award Summary The National Institute on Deafness and Other Communication Disorders (NIDCD) awarded The Jackson Laboratory a $486,750 Project Grant on September 12, 2025, under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The grant funds research exploring morphological changes in supporting cells of the inner ear, with completion targeted for August 31, 2027. The research investigates cell polarity mechanisms that govern the...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $410,534 Project Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded September 10, 2025, with completion targeted for August 31, 2027. This research project investigates genetic modifiers that influence the penetrance of sensorineural hearing loss in the context of endothelin...
- Federal Grant Award Summary Massachusetts Eye and Ear Infirmary received a $388,800 Project Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded May 1, 2025, with completion targeted for March 31, 2030. The grant supports a mentored training plan investigating the PHEX (Phosphate-regulating Endopeptidase Homolog, X-linked) signaling pathway's role in a distinct...
- This Project Grant award of $427,625 was provided by the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173). The objective is to establish the posterior lateral line (PLL) ganglion of larval zebrafish as a model system for studying neuronal repair and replacement in the inner ear. The researchers aim to determine the contributions of neural precursor cell populations to ongoing...
- This $533,978 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD), under the federal Research Related to Deafness and Communication Disorders program (CFDA 93.173), will support research to uncover the molecular basis of otosclerosis. The project aims to analyze rare and common genomic variants in a large cohort of otosclerosis cases and families, as well as identify epigenetic factors implicated in the disease, using advanced genomic and...
ALTERNATIVE SPLICING IN THE MOUSE INNER EAR AT SINGLE CELL RESOLUTION - SENSORINEURAL HEARING LOSS AND VESTIBULAR DYSFUNCTION ARE COMMON SENSORY DISORDERS AFFECTING MILLIONS OF INDIVIDUALS WORLDWIDE1,2. THE PRIMARY CAUSE OF BOTH HEARING LOSS AND PERIPHERAL VESTIBULAR DISORDERS IN HUMANS IS DYSFUNCTION OF THE INNER EAR, WHICH CAN OCCUR AS A RESULT OF NOISE EXPOSURE, AGING, GENETIC DEFECTS, ENVIRONMENTAL EXPOSURE TO PATHOGENS, AND AS A SIDE EFFECT OF OTOTOXIC MEDICATIONS. THERE ARE LIMITED THERAPIES FOR SENSORINEURAL HEARING LOSS AND VESTIBULAR DYSFUNCTION, MAINLY DUE TO THE LACK OF UNDERSTANDING OF SOME OF THE MOLECULAR MECHANISMS THAT GOVERN THE HEARING AND BALANCE ORGANS. THERE REMAIN KEY UNANSWERED QUESTIONS ABOUT THE GENETIC ARCHITECTURE AND MOLECULAR MECHANISMS OF TRANSCRIPTIONAL CONTROL USED DURING MAMMALIAN DEVELOPMENT AND WITHIN THE ADULT INNER EAR. RECENTLY, SINGLE CELL RNA SEQUENCING TECHNOLOGY HAS SHOWN THE REMARKABLE TRANSCRIPTIONAL HETEROGENEITY OF CELL TYPES AND DEVELOPMENTAL DYNAMICS OF THE MOUSE INNER EAR3??. HOWEVER, TRANSCRIPTIONAL DIVERSITY AND CONTROL IS ONLY ONE LEVEL OF GENETIC REGULATION. ONE OF THE KEY UNDERLYING MECHANISMS OF TRANSCRIPTOMIC AND PROTEIN DIVERSITY IS THROUGH ALTERNATIVE SPLICING. CELLS USE ALTERNATIVE SPLICING TO DIVERSIFY THEIR NUMBER OF PROTEINS, CHANGE TRANSLATION EFFICIENCY, CONTROL TRANSCRIPT LOCALIZATION, AND MAKE NON-CODING RNAS?,?. ONLY A LIMITED NUMBER OF GENES THAT UNDERGO ALTERNATIVE SPLICING HAVE BEEN IDENTIFIED IN THE INNER EAR AT CELL TYPE RESOLUTION?. UNDERSTANDING ALTERNATIVE SPLICING OF GENES AT THE SINGLE CELL LEVEL IS CRITICALLY IMPORTANT AS ANY FUTURE THERAPIES TARGETING A SPECIFIC GENE MAY HAVE ON/OFF TARGET EFFECTS IN DIFFERENT SUBSETS OF CELLS. WE HYPOTHESIZE THAT THERE IS CELL TYPE-SPECIFIC DIVERSITY OF ALTERNATIVELY SPLICED MRNA WITHIN THE MAMMALIAN INNER EAR. MOREOVER, REGULATION OF ALTERNATIVE SPLICING EVENTS OCCURS THROUGH SPECIFIC RNA BINDING PROTEINS (RBPS). WE WILL TEST THIS HYPOTHESIS THROUGH TWO AIMS: AIM 1 IS TO CHARACTERIZE THE TRANSCRIPTOME-WIDE ALTERNATIVE SPLICING LANDSCAPE OF THE MOUSE INNER EAR AT SINGLE CELL RESOLUTION. USING NEWLY DEVELOPED COMPUTATIONAL TOOLS, WE WILL IDENTIFY ALTERNATIVELY SPLICED GENES WITHIN BOTH THE DEVELOPING AND ADULT MOUSE INNER EAR FOR THE ENTIRE TRANSCRIPTOME. AIM 2 WILL DETERMINE THE ROLE OF RNA BINDING PROTEINS IN REGULATING ALTERNATIVE SPLICING PROGRAMS IN THE INNER EAR AT SINGLE CELL RESOLUTION. REGULATION OF ALTERNATIVE SPLICING EVENTS IS A KEY POST-TRANSCRIPTIONAL MECHANISM THAT CELLS USE TO DETERMINE WHAT SPLICING PROGRAM MRNA GOES THROUGH AS CARRIED OUT BY RNA BINDING PROTEINS. WE WILL CHARACTERIZE THE EXPRESSION OF RBPS WITHIN THE DEVELOPING MOUSE INNER EAR AND LINK THIS TO ALTERNATIVE SPLICING THROUGH COMPUTATIONAL AND VALIDATION TECHNIQUES TO DEVELOP A SPATIAL AND TEMPORAL MAP OF ALTERNATIVE SPLICING PROGRAMS. IN SUM, WE WILL DEFINE THE HETEROGENEITY OF CELL TYPES BASED ON SINGLE CELL ISOFORM-LEVEL DATA DURING DEVELOPMENT AND IN THE ADULT MAMMALIAN INNER EAR, AND WE WILL IDENTIFY THE KEY PLAYERS IN REGULATING ALTERNATIVE SPLICING. THIS WORK WILL D ALTERNATIVE SPLICING REGULATION DURING DEVELOPMENT AND IN THE ADULT INNER EAR THAT WILL BE NECESSARY FOR FUTURE DEVELOPMENT OF TARGETED INNER EAR THERAPIES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $218.8k | 7/16/25 | ||
| Not listed | $218.8k | 7/26/24 |